Skip to main content
Top
Published in: Pediatric Cardiology 8/2015

Open Access 01-12-2015 | Original Article

Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients

Authors: Robert Jablonowski, Eva Fernlund, Anthony H. Aletras, Henrik Engblom, Einar Heiberg, Petru Liuba, Håkan Arheden, Marcus Carlsson

Published in: Pediatric Cardiology | Issue 8/2015

Login to get access

Abstract

The relationship between hypertrophy, perfusion abnormalities and fibrosis is unknown in young patients with hypertrophic cardiomyopathy (HCM). Since mounting evidence suggests causal relationship between myocardial ischemia and major adverse cardiac events, we sought to investigate whether (1) regional myocardial perfusion is decreased in young HCM patients and in individuals at risk of HCM, and (2) hypoperfused areas are larger than areas with fibrosis. HCM patients (n = 12), HCM-risk subjects (n = 15) and controls (n = 9) were imaged on a 1.5 T MRI scanner. Myocardial hypertrophy was assessed on cine images. Perfusion images were acquired during adenosine hyperemia and at rest. Maximum upslope ratios of perfusion (stress/rest) were used for semiquantitative analysis. Fibrosis was assessed by late gadolinium enhancement (LGE). Results are presented as median and range. Perfusion in HCM-risk subjects and in non-hypertrophied segments in HCM patients showed no difference compared to controls (P = ns). Hypertrophic segments in HCM patients without LGE showed decreased perfusion compared to segments without hypertrophy [1.5 (1.1–2.3) vs. 2.0 (1.8–2.6), P < 0.001], and hypertrophic segments with LGE showed even lower perfusion using a segmental analysis [0.9 (0.6–1.8), P < 0.05]. The extent of hypoperfused myocardium in HCM patients during adenosine exceeded the extent of fibrosis on LGE [20 (0–48) vs. 4 (0–7) % slice area, P < 0.05] and hypoperfused areas at rest (P < 0.001). Regional perfusion is decreased in hypertrophied compared to non-hypertrophied myocardium and is lowest in fibrotic myocardium in young HCM patients but does not discriminate HCM-risk subjects from controls. The stress-induced hypoperfused regions exceed regions with LGE, indicating that hypoperfusion precedes fibrosis and may be a more sensitive marker of diseased myocardium in HCM.
Literature
1.
go back to reference Abdel-Aty H, Cocker M, Strohm O et al (2008) Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 28:242–245CrossRefPubMed Abdel-Aty H, Cocker M, Strohm O et al (2008) Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 28:242–245CrossRefPubMed
2.
go back to reference Aquaro GD, Todiere G, Barison A et al (2011) Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy. J Card Fail 17:384–391CrossRefPubMed Aquaro GD, Todiere G, Barison A et al (2011) Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy. J Card Fail 17:384–391CrossRefPubMed
3.
go back to reference Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708CrossRefPubMed Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708CrossRefPubMed
4.
go back to reference Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998CrossRefPubMed Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998CrossRefPubMed
5.
go back to reference Bravo PE, Zimmerman SL, Luo H-C et al (2013) Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 6:210–217PubMedCentralCrossRefPubMed Bravo PE, Zimmerman SL, Luo H-C et al (2013) Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 6:210–217PubMedCentralCrossRefPubMed
6.
go back to reference Cecchi F, Olivotto I, Gistri R et al (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027–1035CrossRefPubMed Cecchi F, Olivotto I, Gistri R et al (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027–1035CrossRefPubMed
7.
go back to reference Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164CrossRefPubMed Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164CrossRefPubMed
8.
go back to reference Elliott PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218CrossRefPubMed Elliott PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218CrossRefPubMed
9.
go back to reference Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed
10.
go back to reference Gray B, Ingles J, Semsarian C (2011) Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. Int J Cardiol 152:258–259CrossRefPubMed Gray B, Ingles J, Semsarian C (2011) Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. Int J Cardiol 152:258–259CrossRefPubMed
11.
go back to reference Green JJ, Berger JS, Kramer CM, Salerno M (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. J Am Coll Cardiol Cardiovasc Imaging 5:370–377CrossRef Green JJ, Berger JS, Kramer CM, Salerno M (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. J Am Coll Cardiol Cardiovasc Imaging 5:370–377CrossRef
12.
go back to reference Gyllenhammar T, Fernlund E, Jablonowski R et al (2014) Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging 15:1350–1357CrossRefPubMed Gyllenhammar T, Fernlund E, Jablonowski R et al (2014) Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging 15:1350–1357CrossRefPubMed
13.
go back to reference Heiberg E, Ugander M, Engblom H et al (2008) Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom and human study. Radiology 246:581–588CrossRefPubMed Heiberg E, Ugander M, Engblom H et al (2008) Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom and human study. Radiology 246:581–588CrossRefPubMed
14.
go back to reference Heiberg E, Sjögren J, Ugander M et al (2010) Design and validation of Segment: freely available software for cardiovascular image analysis. BMC Med Imaging 10:1–13PubMedCentralCrossRefPubMed Heiberg E, Sjögren J, Ugander M et al (2010) Design and validation of Segment: freely available software for cardiovascular image analysis. BMC Med Imaging 10:1–13PubMedCentralCrossRefPubMed
15.
16.
go back to reference Ho CY, Abbasi SA, Neilan TG et al (2013) T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging 6:415–422PubMedCentralCrossRefPubMed Ho CY, Abbasi SA, Neilan TG et al (2013) T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging 6:415–422PubMedCentralCrossRefPubMed
17.
go back to reference Ismail TF, Hsu L-Y, Greve AM et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy: a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49PubMedCentralCrossRefPubMed Ismail TF, Hsu L-Y, Greve AM et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy: a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49PubMedCentralCrossRefPubMed
18.
go back to reference Ismail TF, Jabbour A, Gulati A et al (2014) Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy. Heart 100:1851–1858CrossRefPubMed Ismail TF, Jabbour A, Gulati A et al (2014) Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy. Heart 100:1851–1858CrossRefPubMed
19.
go back to reference Jerosch-Herold M, Seethamraju RT, Swingen CM et al (2004) Analysis of myocardial perfusion MRI. J Magn Reson Imaging 19:758–770CrossRefPubMed Jerosch-Herold M, Seethamraju RT, Swingen CM et al (2004) Analysis of myocardial perfusion MRI. J Magn Reson Imaging 19:758–770CrossRefPubMed
20.
go back to reference Johansson B, Mörner S, Waldenström A, Stål P (2008) Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis. Int J Cardiol 126:252–257CrossRefPubMed Johansson B, Mörner S, Waldenström A, Stål P (2008) Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis. Int J Cardiol 126:252–257CrossRefPubMed
21.
go back to reference Karamitsos TD, Dass S, Suttie J et al (2013) Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 61:1169–1176PubMedCentralCrossRefPubMed Karamitsos TD, Dass S, Suttie J et al (2013) Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 61:1169–1176PubMedCentralCrossRefPubMed
22.
go back to reference Kim JB, Porreca GJ, Song L et al (2007) Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science 316:1481–1484CrossRefPubMed Kim JB, Porreca GJ, Song L et al (2007) Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science 316:1481–1484CrossRefPubMed
23.
go back to reference Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249CrossRefPubMed Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249CrossRefPubMed
24.
go back to reference Lamke GT, Allen RD, Edwards WD et al (2003) Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. Cardiovasc Pathol 12:149–158CrossRefPubMed Lamke GT, Allen RD, Edwards WD et al (2003) Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. Cardiovasc Pathol 12:149–158CrossRefPubMed
25.
go back to reference Maceira AM, Prasad SK, Khan M, Pennell DJ (2006) Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed Maceira AM, Prasad SK, Khan M, Pennell DJ (2006) Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed
27.
go back to reference Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557CrossRefPubMed Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557CrossRefPubMed
28.
go back to reference Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:785–789CrossRefPubMed Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:785–789CrossRefPubMed
29.
go back to reference Maron MS, Olivotto I, Maron BJ et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866–875CrossRefPubMed Maron MS, Olivotto I, Maron BJ et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866–875CrossRefPubMed
30.
go back to reference Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228CrossRefPubMed Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228CrossRefPubMed
31.
go back to reference Moon JCC, Reed E, Sheppard MN et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260–2264CrossRefPubMed Moon JCC, Reed E, Sheppard MN et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260–2264CrossRefPubMed
32.
go back to reference Petersen SE, Jerosch-Herold M, Hudsmith LE et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115:2418–2425CrossRefPubMed Petersen SE, Jerosch-Herold M, Hudsmith LE et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115:2418–2425CrossRefPubMed
33.
go back to reference Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215–223CrossRefPubMed Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215–223CrossRefPubMed
34.
go back to reference Sipola P, Lauerma K, Husso-Saastamoinen M et al (2002) First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 226:129–137CrossRef Sipola P, Lauerma K, Husso-Saastamoinen M et al (2002) First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 226:129–137CrossRef
35.
go back to reference Soler R, Rodriguez E, Monserrat L et al (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30:412–420CrossRefPubMed Soler R, Rodriguez E, Monserrat L et al (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30:412–420CrossRefPubMed
36.
go back to reference Sotgia B, Sciagrà R, Olivotto I et al (2008) Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med 49:1090–1096CrossRefPubMed Sotgia B, Sciagrà R, Olivotto I et al (2008) Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med 49:1090–1096CrossRefPubMed
37.
go back to reference Tyan CC, Armstrong S, Scholl D et al (2013) Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging. Circ Cardiovasc Imaging 6:229–238CrossRefPubMed Tyan CC, Armstrong S, Scholl D et al (2013) Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging. Circ Cardiovasc Imaging 6:229–238CrossRefPubMed
38.
go back to reference Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482PubMedCentralCrossRefPubMed Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482PubMedCentralCrossRefPubMed
Metadata
Title
Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients
Authors
Robert Jablonowski
Eva Fernlund
Anthony H. Aletras
Henrik Engblom
Einar Heiberg
Petru Liuba
Håkan Arheden
Marcus Carlsson
Publication date
01-12-2015
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 8/2015
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-015-1214-5

Other articles of this Issue 8/2015

Pediatric Cardiology 8/2015 Go to the issue